U
Unicycive Therapeutics D
D
UNCY
4.46000
USD
0.03
(0.68%)
مغلق
حجم التداول
9,752
الربح لكل سهم
-2
العائد الربحي
-
P/E
-2
حجم السوق
78,771,173
العنوان: Unicycive Therapeutics Inc
القطاع: Healthcare
الصناعة: Biotechnology
Unicycive Therapeutics Inc is a biotechnology company dedicated to developing treatments for certain medical conditions. It is focusing on kidney diseases. The company's manufactures drug, Renazorb, is a novel phosphate-binding agent beingdeveloped for the treatment of hyperphosphatemia. Unicycive's other drug, UNI-494, is a new chemical entity with the issued composition of matter patent protection in late preclinical development for the treatment of acute kidney injury. Company's pipeline comprised of two product candidates: Oxylanthanum Carbonate and UNI-494.